WBC
MRNA icon

Westpac Banking Corp’s Moderna MRNA Stock Holding History

Westpac Banking Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,672
Closed -$104K – 476
2025
Q1 		$104K Sell
3,672
-1,460
-28% -$51.8K 0.01% 401
2024
Q4 		$213K Buy
5,132
+921
+22% +$44K 0.01% 358
2024
Q3 		$281K Hold
4,211
– – 0.02% 336
2024
Q2 		$500K Buy
4,211
+455
+12% +$57.6K 0.04% 249
2024
Q1 		$400K Sell
3,756
-49
-1% -$4.94K 0.03% 274
2023
Q4 		$378K Buy
3,805
+476
+14% +$40K 0.03% 275
2023
Q3 		$344K Buy
3,329
+329
+11% +$36.7K 0.03% 339
2023
Q2 		$365K Sell
3,000
-27,123
-90% -$3.62M 0.03% 330
2023
Q1 		$4.63M Sell
30,123
-62
-0.2% -$10.2K 0.06% 353
2022
Q4 		$5.42M Buy
30,185
+1,998
+7% +$327K 0.08% 309
2022
Q3 		$3.33M Sell
28,187
-3,974
-12% -$603K 0.05% 401
2022
Q2 		$4.59M Sell
32,161
-1,686
-5% -$241K 0.06% 389
2022
Q1 		$5.83M Buy
33,847
+5,553
+20% +$935K 0.07% 352
2021
Q4 		$7.19M Buy
28,294
+1,164
+4% +$340K 0.07% 319
2021
Q3 		$10.4M Sell
27,130
-2,378
-8% -$877K 0.11% 237
2021
Q2 		$6.93M Buy
29,508
+4,430
+18% +$792K 0.07% 364
2021
Q1 		$3.28M Buy
25,078
+1,684
+7% +$244K 0.04% 480
2020
Q4 		$2.44M Buy
23,394
+5,394
+30% +$546K 0.03% 536
2020
Q3 		$1.27M Hold
18,000
– – 0.02% 617
2020
Q2 		$1.16M Buy
+18,000
New +$986K 0.02% 612

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Westpac Banking Corp's MRNA Position: Q2 2025 in Review

Westpac Banking Corp sold out of Moderna (MRNA) in Q2 2025, closing a stake of 3,672 shares — an estimated $104K sold.

Westpac Banking Corp first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $10.4M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Westpac Banking Corp reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Westpac Banking Corp sold 3,672 Moderna shares in Q2 2025, an estimated $104K.
  • Westpac Banking Corp first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Westpac Banking Corp's Moderna position peaked at $10.4M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Westpac Banking Corp's 13F filing for Q2 2025, filed 11 Aug 2025.